Summary
The neutralization epitopes of human rotavirus VP4 were studied by using a panel of neutralizing monoclonal antibodies previously shown to be strain-specific (RV-3:3), serotype-specific (RV-5:2, ST-3:3) or cross-reactive (F45:4). Antigenic variants of human rotaviruses RV-3, ST-3, RV-5 and F45 resistant to neutralization by the appropriate of VP4 specific monoclonal antibodies (RV-3:3, ST-3:3, RV-5:2 and F45:4 respectively) were selected. By nucleotide sequence analysis and single strand conformational polymorphism analysis of these variants, three sites of neutralization on VP5* and one site on VP8* were identified. At or near to the putative fusion region on VP5*, a strain-specific site (aa383), a serotype P1A-P2 cross-reactive site (aa392) and a serotype P2-specific site (aa397) were found. On VP8*, a serotype P1B-specific site at aa148 was detected. These results confirmed the importance of the putative fusion region in neutralization and have identified a new neutralization site in the hypervariable region of VP8* which is specific for serotype P1B human rotaviruses.
Similar content being viewed by others
References
Bishop RF (1995) Natural history of human rotavirus infections. In: Kapikian AZ (ed) Viral infections of the gastrointestinal tract, 2nd ed. Marcel Dekker, New York, pp 131–167
Chen D, Estes MK, Ramig RF (1992) Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J Virol 66: 432–439
Coulson BS (1993) Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies. J Clin Microbiol 31: 1–8
Coulson BS, Fowler KJ, Bishop RF, Cotton RGH (1985) Neutralizing monoclonal antobodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol 54: 14–20
Coulson BS, Kirkwood C (1991) Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J Virol 65: 5968–5974
Coulson BS, Tursi JM, McAdam WJ, Bishop RF (1986) Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology 154: 301–312
Dyall-Smith ML, Holmes IH (1984) Sequence homology between human and animal rotavirus serotype-specific glycoproteins. Nucleic Acids Res 12: 3973–3982
Estes MK, Cohen J (1989) Rotavirus genome structure and function. Microbiol Rev 53: 410–449
Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30: 1365–1373
Gorziglia M, Green K, Nishikawa K, Taniguchi K, Jones R, Kapikian AZ, Chanock RM (1988) Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol 62: 2978–2984
Gorziglia M, Larralde G, Kapikian AZ, Chanoch RM (1990) Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci USA 87: 7155–7159
Hoshino Y, Wyatt RG, Flores J, Midthun K, Kapikian AZ (1985) Serotypic characterization of rotavirus derived from asymptomatic human neonatal infections. J Clin Microbiol 21: 425–430
Isegawa Y, Nakagomi O, Nakagomi T, Ueda S (1992) A VP4 sequence highly conserved in human rotavirus strain Au-1 and feline rotavirus strain FRV-1. J Gen Virol 73: 1939–1946
Kalica AR, Flores J, Greenberg HB (1983) Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology 125: 194–205
Kaljot KT, Shaw RD, Rubin DH, Greenberg HB (1988) Infectious rotavirus enters cells by direct cell membrane pentration, not endocytosis. J Virol 62: 1136–1144
Kapikian AZ, Chanock RM (1990) Rotaviruses. In: Fields BN, Knipe DN, Melnick JL, Chanock CM, Roizman B, Shope RE (eds) Virology, vol 2. Raven Press, New York, pp 1353–1404
Katayama K, Oya A, Tanabayashi K, Okazaki K, Hishiyama M, Yamazaki S, Yamada A (1993) Differentiation of mumps vaccine strains from wild virus by single-strand conformation polymorphism of the P gene. Vaccine 11: 621–623
Kirkwood C, Masendycz PJ, Coulson BS (1993) Characterization and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotavirus. Virology 196: 79–88
Kobayashi N, Taniguchi K, Urasawa S (1990) Identification of operationally overlapping and independent cross-reactive neutralizations regions on human rotavirus VP4. J Gen Virol 71: 2615–2623
Larralde G, Flores J (1990) Identification of gene 4 alleles among human rotaviruses by polymerase chain reaction-derived probes. Virology 179: 469–473
Larralde G, Gorziglia M (1992) Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4. J Virol 66: 7438–7443
Larralde G, Li B, Kapikian AZ, Gorziglia M (1991) Serotype-specific epitopes(s) present on the VP8* subunit of rotavirus VP4 protein. J Virol 65: 3213–3218
Lazdins I, Coulson BS, Kirkwood C, Dyall-Smith M, Masendycz PJ, Sonza S, Holmes IH (1995) Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7. Virology 209: 80–89
Li B, Larralde G, Gorziglia M (1993) Human rotavirus K8 strain represents a new VP4 serotype. J Virol 65: 1658–1661
Mackow ER, Shaw RD, Matsui SM, Vo PT, Dang MN, Greenberg HB (1988) Characterization of the rhesus rotavirus VP3 gene: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci USA 85: 645–649
Offit PA, Blavat G, Greenberg HN, Clark HF (1986) Molecular basis for rotavirus virulence: role of gene segment 4. J Virol 57: 46–49
Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766–2770
Padilla-Noriega L, Dunn SJ, Lopez S, Greenberg HB, Arias CF (1995) Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human ST3. Virology 206: 148–154
Padilla-Noriega L, Werner-Eckert R, Mackow ER, Gorziglia M, Larralde G, Taniguchi K, Greenberg HB (1993) Serologic analysis of human rotavirus serotypes P1A ans P2 by using monoclonal antibodies. J Clin Microbiol 31: 622–628
Prasad BV, Wang GJ, Clerx JP, Chiu W (1988) Three-dimensional structure of rotavirus. J Mol Biol 199: 269–275
Shaw RD, Vo PT, Offit PA, Coulson BS, Greenberg HB (1986) Antigenic mapping of the surface proteins of rhesus rotavirus. Virology 155: 434–451
Taniguchi K, Maloy WL, Nishikawa K, Green KY, Hoshino Y, Urasawa S, Kapikian AZ, Chanock RM, Gorziglia M (1988) Identification of cross-reactive and serotype-specific neutralization epitopes on VP3 of human rotavirus. J Virol 62: 2421–2426
Taniguchi K, Nishikawa K, Urasawa T, Urasawa S, Midthun K, Kapikian AZ, Gorziglia M (1989) Complete sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes. J Virol 63: 4101–4106
Xi LF, Demers GW, Kiviat NB, Kuypers J, Beckmann AM, Galloway DA (1993) Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. J Infect Dis 168: 610–617
Yeager M, Dryden KA, Olson NH, Greenberg HB, Baker TS (1990) Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol 110: 2133–2144
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kirkwood, C.D., Bishop, R.F. & Coulson, B.S. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites. Archives of Virology 141, 587–600 (1996). https://doi.org/10.1007/BF01718319
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01718319